# Phase 2c Dose Comparison Study of MP4OX in Trauma

> **NCT01973504** · PHASE2 · WITHDRAWN · sponsor: **Sangart**

## Conditions studied

- Trauma
- Hemorrhagic Shock
- Lactic Acidosis

## Interventions

- **DRUG:** MP4OX
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT01973504
- **Lead sponsor:** Sangart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-12
- **Primary completion:** 2015-12
- **Final completion:** 2016-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sangart ceased operations
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01973504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01973504, "Phase 2c Dose Comparison Study of MP4OX in Trauma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01973504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*